Status:
TERMINATED
Effect of Cocoa Consumption in Cardiovascular and Immune Parameters
Lead Sponsor:
Universidad de Antioquia
Conditions:
Arterial Hypertension
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Arterial hypertension is one of the most preventable risk factors for stroke, cardiovascular and renal disease. Cocoa is rich in a subclass of flavonoid called flavanol this increase nitric oxide prod...
Eligibility Criteria
Inclusion
- Age: 18 - 65 years old
- Resides in Medellín City
- Attached from the contributive regimen of Colombian Health System
- Essential Arterial Hypertension, stage I. Diagnosis less than 3 months.
- Medically indicated non-pharmacological therapy.
- Voluntary desire to consume 50 grams of chocolate per day for 12 weeks.
- Voluntary desire to participate in the trial and sign informed consent.
Exclusion
- Suspect of secondary hypertension
- Suspect of injury in target organ
- Presence of diabetes mellitus
- BMI (Body Mass Index) major or equal to 30
- Present smoker or with less than four weeks of abstinence of tobacco
- Consume antiplatelet substances
- Regular consumption of antioxidants, multivitamins, anti-inflammatory medications, drugs for nasal congestion and sibutramine
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01496235
Start Date
July 1 2009
End Date
July 1 2011
Last Update
December 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sede Investigaciones Universitarias, Universidad de Antioquia
Medellín, Antioquia, Colombia